130 likes | 263 Views
IRC Process. NVS IRC October 2012. Aims. To highlight the process by which GAVI makes commitments To describe the data on which these commitments are made The limitations of the current approach Current/future steps to address these issues. Process for making commitments.
E N D
IRC Process NVS IRC October 2012
Aims • To highlight the process by which GAVI makes commitments • To describe the data on which these commitments are made • The limitations of the current approach • Current/future steps to address these issues
Process for making commitments • Country programmes are GAVI’s core business • NVS, HSS, CSO • Independent Review Committee (IRC) was designed to respond to country needs and recommend support for high quality programmes • Built on principles: • Independence • Country based request
Process for making commitments • The IRC relies upon a wide range of experts • Expertise in public health, epidemiology, immunization, logistics, health systems, development, and economics • The Committee is based on a system of peer review • Each country submission is pre-screened for accuracy and consistency by UNICEF, WHO and for completeness by the GAVI Secretariat before being submitted to the IRC
Process for making commitments New Proposals IRC • Recommends Board endorsement of multiyear commitments aligned with comprehensive multi-year plans (cMYP) for immunisation and health sector plans • Recommends Board approval of first year of budget for a multi-year commitment Monitoring IRC has two roles • Review performance for previous year • Recommends Board approval of the following year’s support • Recommends Board endorsement of multiyear commitments for extensions/renewals of support
Process for making commitments • Originally, GAVI NVS support was for 5 years • In GAVI’s second phase of support, for NVS • Aligned cMYPs which can be for a 1, 2 or 5 years of duration • Secretariat and partners proposed process for making extension and renewals of NVS
Process for making commitments • Monitoring IRC recommends extension/renewals based on: • Performance from previous year for new targets • Duration of new cMYP for extension
Data for NVS commitments: Country-driven • Official data utilized for national planning • Calculation of doses based on: • 1st dose targets x • Doses of schedule x • Wastage (WHO recommendation) + • 25% for buffer (for 1st year) or – • Co-financing • Financial implications: doses x prices + supplies and freight
Outcomes of IRC Process • Updated financial commitments for Finance to prepare financial plan/projections • Updated quantity of doses to be supported by GAVI and co-financed to revise the adjusted demand forecast • Decision letters to communicate approvals to countries and UNICEF SD (after Board) • Progress and performance report
Limitations of the current approach • Geneva based/“paper review” (limited verification) • Based on countries own data • National health information systems need strengthening • Data quality issues (denominators/nominators) • Stock management and logistics (vaccines and drugs) monitoring systems could be improved • Alignment with planning, fiscal and reporting cycles could be improved
Current/future steps to address these issues • Review of the IRC process • Process and requirements • Review minimum requirements for applications • Formal cold chain & vaccine management assessments (EVSM/VMA) (based on recommendations from CCL Task Force) • Improving triangulation with WHO&UNICEF to obtain live information on vaccine stocks • Cash-based support governed by country partnership